Viktoriia V. Hutsol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Viktoriia V. Hutsol has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Vasyl M. Koval
Вінницький національний медичний університет імені М.І. Пирогова
5 shared publications - Olena Toziuk
National Pirogov Memorial Medical University
4 shared publications - Olena V. Kryvoviaz
Вінницький національний медичний університет імені М.І. Пирогова
4 shared publications - Yuliia O. Tomashevska
Вінницький національний медичний університет імені М. І. Пирогова
3 shared publications - Olesya P. Balitska
Вінницький національний медичний університет імені М. І. Пирогова
2 shared publications - Alona Voronkina
Department of Pharmacy, National Pirogov Memorial Medical University, Vinnytsya, Pyrogova 56, 21018 Vinnytsia, Ukraine
1 shared publication
Latest Publications
- 22 April 2026
- Published by Ternopil State Medical University in Здобутки клінічної і експериментальної медицини
- No. 1,p. 5-11
ADDITIVE TECHNIQUES AND BIOPRINTERS IN PHARMACEUTICAL INDUSTRY: A REVIEW OF MODERN APPLICATIONS
SUMMARY. The aim – to search in informational-scientific and sciencemetric data bases such as Scopus, Web of Science and PubMed by the key words: additive techniques, 3D printing, medicines, cosmetics, manufacturing, personalized medicine, for systematizing of scientific professional literature data in regarding the implementation of additive techniques and bioprinting in the production of medicinal and cosmetic products, assessing the advantages and constraints of the techniques as well as to prognose the ways of future research directions in this field. Material and Methods. The source material for the study was derived from scientific publications of domestic and foreign authors presented in professional peer-reviewed publications and electronic scientific databases dedicated to application of additive techniques in pharmaceutical and cosmetic industries. For our research we used the methods of systemic analysis, comparative and generalization of literary sources, as well as logical and structural processing of information. Results. The modern healthcare system is undergoing a fundamental transformation shifting the focus on personalized medicine. The adaptation of therapy to the individual needs of patients in context of pharmacogenetics, metabolism and physiological characteristics has become the mainstream of the pharmaceutical industry. The techniques are focused on layer-by-layer objects based on digital models for designing medicines with complex geometry, controlled active substance release, and the ability to combine several active ingredients in a single dose. Inkjet printing, fused deposition modeling (FDM), selective laser sintering (SLS), stereolithography (SLA) and pressure-assisted microsyringe (PAM) are the techniques currently being practically tested by pharmacists and cosmetologists for the above purposes. Conclusions. We summarized current information on application of additive techniques in manufacture of medicines and cosmeceutical products. 3D printing has been shown to enable to create personalized medicinal and cosmetic formulations with controlled structure and release profile. Bioprinting has been proven to boost the potential of preclinical screening and alternative safety models, particularly in cosmetology and regenerative medicine. However, widespread adoption of these techniques is hampered by technological and regulatory constraints.
- 22 April 2026
- Published by Ternopil State Medical University in Здобутки клінічної і експериментальної медицини
- No. 1,p. 5-11
ADDITIVE TECHNIQUES AND BIOPRINTERS IN PHARMACEUTICAL INDUSTRY: A REVIEW OF MODERN APPLICATIONS
SUMMARY. The aim – to search in informational-scientific and sciencemetric data bases such as Scopus, Web of Science and PubMed by the key words: additive techniques, 3D printing, medicines, cosmetics, manufacturing, personalized medicine, for systematizing of scientific professional literature data in regarding the implementation of additive techniques and bioprinting in the production of medicinal and cosmetic products, assessing the advantages and constraints of the techniques as well as to prognose the ways of future research directions in this field. Material and Methods. The source material for the study was derived from scientific publications of domestic and foreign authors presented in professional peer-reviewed publications and electronic scientific databases dedicated to application of additive techniques in pharmaceutical and cosmetic industries. For our research we used the methods of systemic analysis, comparative and generalization of literary sources, as well as logical and structural processing of information. Results. The modern healthcare system is undergoing a fundamental transformation shifting the focus on personalized medicine. The adaptation of therapy to the individual needs of patients in context of pharmacogenetics, metabolism and physiological characteristics has become the mainstream of the pharmaceutical industry. The techniques are focused on layer-by-layer objects based on digital models for designing medicines with complex geometry, controlled active substance release, and the ability to combine several active ingredients in a single dose. Inkjet printing, fused deposition modeling (FDM), selective laser sintering (SLS), stereolithography (SLA) and pressure-assisted microsyringe (PAM) are the techniques currently being practically tested by pharmacists and cosmetologists for the above purposes. Conclusions. We summarized current information on application of additive techniques in manufacture of medicines and cosmeceutical products. 3D printing has been shown to enable to create personalized medicinal and cosmetic formulations with controlled structure and release profile. Bioprinting has been proven to boost the potential of preclinical screening and alternative safety models, particularly in cosmetology and regenerative medicine. However, widespread adoption of these techniques is hampered by technological and regulatory constraints.
- 30 December 2025
- Published by ALUNA in Wiadomości Lekarskie
- No. 12,p. 2742-2750
Intellectual analysis of criteria that influence the choice of medicines for dispensing by electronic prescriptions
Aim: Identifying of key criteria that influence the process of dispensing medicines by pharmacists by electronic prescriptions, and establish its’ relationship with the frequency of problems while paying off prescriptions. Material and methods: In our work we used the survey method involving questionnaires. To screen the obtained results, we used the method of intelligent data analysis depending on building the associative rules. Results: We analyzed the criteria that had influenced a choice of trade name of prescription medicines filled for patients by a pharmacist under e-prescription in the form of an international non-proprietary name. Conclusions: We have determined the criteria for selecting medicinal products by pharmaceutical clerks while filling e-prescriptions, which can be used in the practical activities of pharmaceutical workers as an integral part of the process of optimizing pharmacy inventories. The most important criteria have been found the amount of co-payment for medicine, the country of manufacture/medicines manufacturer, and the history of medicine administration by the patient. The criteria of the presence or absence of evidence-based data on the efficacy of a particular medicine and the medicine`s belonging to generics or original medicines have been found the least important. The inability of a pharmaceutical clerk/pharmacy worker to select a medicine based on one or more of the above selection criteria is considered one of the reasons for failure to dispense up to 20% of medicinal products under e-prescriptions.
- 30 December 2025
- Published by ALUNA in Wiadomości Lekarskie
- No. 12,p. 2742-2750
Intellectual analysis of criteria that influence the choice of medicines for dispensing by electronic prescriptions
Aim: Identifying of key criteria that influence the process of dispensing medicines by pharmacists by electronic prescriptions, and establish its’ relationship with the frequency of problems while paying off prescriptions. Material and methods: In our work we used the survey method involving questionnaires. To screen the obtained results, we used the method of intelligent data analysis depending on building the associative rules. Results: We analyzed the criteria that had influenced a choice of trade name of prescription medicines filled for patients by a pharmacist under e-prescription in the form of an international non-proprietary name. Conclusions: We have determined the criteria for selecting medicinal products by pharmaceutical clerks while filling e-prescriptions, which can be used in the practical activities of pharmaceutical workers as an integral part of the process of optimizing pharmacy inventories. The most important criteria have been found the amount of co-payment for medicine, the country of manufacture/medicines manufacturer, and the history of medicine administration by the patient. The criteria of the presence or absence of evidence-based data on the efficacy of a particular medicine and the medicine`s belonging to generics or original medicines have been found the least important. The inability of a pharmaceutical clerk/pharmacy worker to select a medicine based on one or more of the above selection criteria is considered one of the reasons for failure to dispense up to 20% of medicinal products under e-prescriptions.
- Open Access
- 28 March 2025
- Published by National University of Pharmacy in Social Pharmacy in Health Care
- Vol. 10 (4) , 81-88
The frequency and VEN analysis of medical prescriptions for patients with duodenal ulcer disease in healthcare institutions
Aim. To perform the frequency and VEN analysis of medical prescriptions for patients with duodenal ulcer disease (DUD) in a healthcare institution. Materials and methods. Depersonalized information base containing data from 112 histories of patients with DUD who were treated in one of the healthcare institutions in Vinnytsia, prescription sheets, the National List of Essential Medicines, the Unified Clinical Protocol of Primary and Specialized Medical Care “Peptic ulcer of the stomach and duodenal ulcer in adults and children” (2023), the State Formulary of Medicines (2023) were used. Research methods such as retrospective, system-analytical, frequency and VEN analysis were applied. Results. As a result of the frequency and VEN analysis conducted during the study period, doctors prescribed a total of 48 active substances by INN and 109 drugs by trade names (TN). A total of 817 drugs were prescribed by TN. According to the results of this analysis, it was found that the largest number of prescriptions fell on proton pump inhibitors of different generations (21.3 % of all prescriptions) and multienzyme drugs (15.06 % of all prescriptions). For the eradication of Helicobacter pylori, agents for the treatment of peptic ulcer and gastroesophageal reflux disease, combinations for the eradication of Helicobacter pylori were prescribed (14.89 % of all prescriptions). There were also many prescriptions from groups of drugs affecting the digestive system (13.89 %). For the treatment of concomitant pathologies, drugs used to treat the liver and biliary tract (4.28 %), intestinal anti-inflammatory drugs (2.08 %), anti-anemic drugs (1.46 %), antibacterial drugs, antibiotics, hypolipidemic, hypnotic, sedative drugs, antidepressants, etc., were prescribed. It was proved that the main of pharmacotherapy of DUD was etiological and pathogenetic therapy. According to the VEN analysis, 8 drugs (17 %) were included in category V, 22 drugs (46 %) – in category E, and 18 drugs (37 %) – in category N, out of 48 drugs by INN. Conclusions. Therefore, the study conducted showed that a significant number of prescriptions and financial resources were directed to the use of secondary drugs that were not included in the regulatory legal acts regulating the pharmaceutical provision of patients with DUD.
- 28 March 2025
- Published by National University of Pharmacy in Social Pharmacy in Health Care
- Vol. 10 (4) , 81-88
Open AccessThe frequency and VEN analysis of medical prescriptions for patients with duodenal ulcer disease in healthcare institutions
Aim. To perform the frequency and VEN analysis of medical prescriptions for patients with duodenal ulcer disease (DUD) in a healthcare institution. Materials and methods. Depersonalized information base containing data from 112 histories of patients with DUD who were treated in one of the healthcare institutions in Vinnytsia, prescription sheets, the National List of Essential Medicines, the Unified Clinical Protocol of Primary and Specialized Medical Care “Peptic ulcer of the stomach and duodenal ulcer in adults and children” (2023), the State Formulary of Medicines (2023) were used. Research methods such as retrospective, system-analytical, frequency and VEN analysis were applied. Results. As a result of the frequency and VEN analysis conducted during the study period, doctors prescribed a total of 48 active substances by INN and 109 drugs by trade names (TN). A total of 817 drugs were prescribed by TN. According to the results of this analysis, it was found that the largest number of prescriptions fell on proton pump inhibitors of different generations (21.3 % of all prescriptions) and multienzyme drugs (15.06 % of all prescriptions). For the eradication of Helicobacter pylori, agents for the treatment of peptic ulcer and gastroesophageal reflux disease, combinations for the eradication of Helicobacter pylori were prescribed (14.89 % of all prescriptions). There were also many prescriptions from groups of drugs affecting the digestive system (13.89 %). For the treatment of concomitant pathologies, drugs used to treat the liver and biliary tract (4.28 %), intestinal anti-inflammatory drugs (2.08 %), anti-anemic drugs (1.46 %), antibacterial drugs, antibiotics, hypolipidemic, hypnotic, sedative drugs, antidepressants, etc., were prescribed. It was proved that the main of pharmacotherapy of DUD was etiological and pathogenetic therapy. According to the VEN analysis, 8 drugs (17 %) were included in category V, 22 drugs (46 %) – in category E, and 18 drugs (37 %) – in category N, out of 48 drugs by INN. Conclusions. Therefore, the study conducted showed that a significant number of prescriptions and financial resources were directed to the use of secondary drugs that were not included in the regulatory legal acts regulating the pharmaceutical provision of patients with DUD.
- Open Access
- 30 November 2023
- Published by Ternopil State Medical University in Фармацевтичний часопис
- No. 4,p. 63-69
АНАЛІЗ ФІЗИЧНОЇ ДОСТУПНОСТІ ФАРМАЦЕВТИЧНОЇ ДОПОМОГИ У ВІННИЦЬКІЙ ОБЛАСТІ
The aim of the work. The analysis of the physical accessibility of the population of the Vinnytsia region to pharmaceutical aid according to the level of concentration of economic entities that have a license for retail trade in medicines and medical products and are permanently operating. Materials and Methods. The methods of scientific generalization, statistical, retrospective analysis and grouping pharmacies based on their physical location in the Vinnytsia region has been used to analyze the population's access to pharmaceutical aid. Tha analysis has been based on data from reports on the results of the State Service of Ukraine for Medicines and Drug Control in 2017-2022, data from the License Register for Production of medicines (in the pharmacy conditions), wholesale and retail trade of medicines as of May 1, 2023, statistical data on the population of the Vinnytsia region. Results and Discussion. It was established that as of May 2023, there are 312 business entities registered in the territory of Vinnytsia region that have a license for the retail trade of medicines and medical products in 878 places of activity. 685 pharmacies are permanently operating. 66% of pharmacies are concentrated in cities, 19% and 15% in urban-type settlements and villages, respectively. Only 3 pharmacies in the region have a license, which allows the compounding of medicines in pharmacies. Conclusions. The absolute majority of pharmacies in the Vinnytsia region are located in cities. Almost 30% of the total number of permanently functioning pharmacies located in the region is concentrated in the regional center. There is a significant differentiation in terms of availability of pharmacies between administrative and territorial units – residents of only 5% of villages have physical access to pharmaceutical care in their settlements. The majority among the organizational and legal forms of business that carry out the retail sale of medicinal products in the Vinnytsia region are limited liability companies and individual entrepreneurs with the maximum number of places of activity 6 and 70, respectively. Мета роботи. Аналіз фізичної доступності населення Вінницької області до фармацевтичної допомоги за рівнем концентрації суб’єктів господарювання, що мають ліцензію на роздрібну торгівлю лікарськими засобами та виробами медичного призначення і здійснюють свою роботу у безперебійному режимі. Матеріали та методи. Для аналізу доступності населення до фармацевтичної допомоги використовували методи наукового узагальнення, статистичного, ректроспективного аналізу та групування аптечних закладів з огляду на їх фізичне розташування у Вінницькій області на основі опрацювання даних звітів про підсумки діяльності Державної служби України з лікарських засобів та контролю за наркотиками у 2017-2022 роках, даних Ліцензійного реєстру з виробництва лікарських засобів (в умовах аптеки), оптової та роздрібної торгівлі лікарськими засобами станом на 1 травня 2023 року, статистичні дані про чисельність населення Вінницької області. Результати й обговорення. Встановлено, що на території Вінницької області станом на травень 2023 року зареєстровано 312 суб’єктів господарювання, що мають ліцензію на роздрібну торгівлю лікарськими засобами та виробами медичного призначення у 878 місцях провадження діяльності. Постійно працюючими є 685 аптечних закладів. В містах зосереджено 66 % аптечних закладів, в селищах міського типу та селах 19 % та 15 % відповідно. Лише 3 аптечних заклади в області мають ліцензію, що дозволяє здійснювати виробництво лікарських засобів в умовах аптеки. Висновки. Абсолютна більшість аптечних закладів Вінницької області розташована у містах; у обласному центрі сконцентровано майже 30 % від всієї кількості постійно функціонуючих аптечних закладів, розташованих у області, та спостерігається суттєва диференціація між адміністративно-територіальними одиницями за забезпеченістю аптечними закладами; мешканці лише 5% сіл мають фізичну доступність до фармацевтичної допомоги у своїх населених пунктах; серед організаційно-правових форм господарювання, що здійснюють роздрібну реалізацію лікарських засобів у Вінницькій області, переважну частину становлять товариства з обмеженою...
- 30 November 2023
- Published by Ternopil State Medical University in Фармацевтичний часопис
- No. 4,p. 63-69
Open AccessАНАЛІЗ ФІЗИЧНОЇ ДОСТУПНОСТІ ФАРМАЦЕВТИЧНОЇ ДОПОМОГИ У ВІННИЦЬКІЙ ОБЛАСТІ
The aim of the work. The analysis of the physical accessibility of the population of the Vinnytsia region to pharmaceutical aid according to the level of concentration of economic entities that have a license for retail trade in medicines and medical products and are permanently operating. Materials and Methods. The methods of scientific generalization, statistical, retrospective analysis and grouping pharmacies based on their physical location in the Vinnytsia region has been used to analyze the population's access to pharmaceutical aid. Tha analysis has been based on data from reports on the results of the State Service of Ukraine for Medicines and Drug Control in 2017-2022, data from the License Register for Production of medicines (in the pharmacy conditions), wholesale and retail trade of medicines as of May 1, 2023, statistical data on the population of the Vinnytsia region. Results and Discussion. It was established that as of May 2023, there are 312 business entities registered in the territory of Vinnytsia region that have a license for the retail trade of medicines and medical products in 878 places of activity. 685 pharmacies are permanently operating. 66% of pharmacies are concentrated in cities, 19% and 15% in urban-type settlements and villages, respectively. Only 3 pharmacies in the region have a license, which allows the compounding of medicines in pharmacies. Conclusions. The absolute majority of pharmacies in the Vinnytsia region are located in cities. Almost 30% of the total number of permanently functioning pharmacies located in the region is concentrated in the regional center. There is a significant differentiation in terms of availability of pharmacies between administrative and territorial units – residents of only 5% of villages have physical access to pharmaceutical care in their settlements. The majority among the organizational and legal forms of business that carry out the retail sale of medicinal products in the Vinnytsia region are limited liability companies and individual entrepreneurs with the maximum number of places of activity 6 and 70, respectively. Мета роботи. Аналіз фізичної доступності населення Вінницької області до фармацевтичної допомоги за рівнем концентрації суб’єктів господарювання, що мають ліцензію на роздрібну торгівлю лікарськими засобами та виробами медичного призначення і здійснюють свою роботу у безперебійному режимі. Матеріали та методи. Для аналізу доступності населення до фармацевтичної допомоги використовували методи наукового узагальнення, статистичного, ректроспективного аналізу та групування аптечних закладів з огляду на їх фізичне розташування у Вінницькій області на основі опрацювання даних звітів про підсумки діяльності Державної служби України з лікарських засобів та контролю за наркотиками у 2017-2022 роках, даних Ліцензійного реєстру з виробництва лікарських засобів (в умовах аптеки), оптової та роздрібної торгівлі лікарськими засобами станом на 1 травня 2023 року, статистичні дані про чисельність населення Вінницької області. Результати й обговорення. Встановлено, що на території Вінницької області станом на травень 2023 року зареєстровано 312 суб’єктів господарювання, що мають ліцензію на роздрібну торгівлю лікарськими засобами та виробами медичного призначення у 878 місцях провадження діяльності. Постійно працюючими є 685 аптечних закладів. В містах зосереджено 66 % аптечних закладів, в селищах міського типу та селах 19 % та 15 % відповідно. Лише 3 аптечних заклади в області мають ліцензію, що дозволяє здійснювати виробництво лікарських засобів в умовах аптеки. Висновки. Абсолютна більшість аптечних закладів Вінницької області розташована у містах; у обласному центрі сконцентровано майже 30 % від всієї кількості постійно функціонуючих аптечних закладів, розташованих у області, та спостерігається суттєва диференціація між адміністративно-територіальними одиницями за забезпеченістю аптечними закладами; мешканці лише 5% сіл мають фізичну доступність до фармацевтичної допомоги у своїх населених пунктах; серед організаційно-правових форм господарювання, що здійснюють роздрібну реалізацію лікарських засобів у Вінницькій області, переважну частину становлять товариства з обмеженою...
- Open Access
- 29 September 2022
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 26 (3) , 458-461
Shaping and implementing the individual educational trajectory of the acquirers of higher education of the pharmaceutical department
Annotation. Higher education, particularly in Branch 22 “Health Care”, is currently in the state of intense dynamic development and reformatting. This is mainly caused by the search for new efficient educational techniques, digitalization of all spheres of life, the influence of coronavirus COVID-19 pandemics and other factors. The article generalizes the experience of working with the acquires of higher education on the basis of student-centric approach and education personalization. The purpose of the paper was to describe the theoretical aspects and way of implementing the individual educational trajectory of the acquirers of higher education of the pharmaceutical department, specialty 226 “Pharmacy, Industrial Pharmacy” of the educational-professional program “Pharmacy, Industrial Pharmacy” at the National Pirogov Memorial Medical University, Vinnytsya. The planning and organization of the work with the acquirers of higher education were based on the provisions of the current legislation, which regulate the educational process in Ukraine as well as in the above mentioned institution of higher education and facilitate the integration in the European educational space. Firstly, the accompanying documentation of every course was structured and reviewed in accordance with current requirements. Syllabuses, being the acquirer’s main source of information about the educational components, are adapted as much as possible to be understandable and accessible. All documents are posted in the public domain on the web pages of the departments. Considerable attention is paid to the formation of professional competences, which ensure the study results, outlined in the course curriculum. At the same time, personalization of education is implemented through the development of personal skills and interests of an acquirer at elective components of the educational program as well as during extracurricular scientific and civic activities.
- 29 September 2022
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 26 (3) , 458-461
Open AccessShaping and implementing the individual educational trajectory of the acquirers of higher education of the pharmaceutical department
Annotation. Higher education, particularly in Branch 22 “Health Care”, is currently in the state of intense dynamic development and reformatting. This is mainly caused by the search for new efficient educational techniques, digitalization of all spheres of life, the influence of coronavirus COVID-19 pandemics and other factors. The article generalizes the experience of working with the acquires of higher education on the basis of student-centric approach and education personalization. The purpose of the paper was to describe the theoretical aspects and way of implementing the individual educational trajectory of the acquirers of higher education of the pharmaceutical department, specialty 226 “Pharmacy, Industrial Pharmacy” of the educational-professional program “Pharmacy, Industrial Pharmacy” at the National Pirogov Memorial Medical University, Vinnytsya. The planning and organization of the work with the acquirers of higher education were based on the provisions of the current legislation, which regulate the educational process in Ukraine as well as in the above mentioned institution of higher education and facilitate the integration in the European educational space. Firstly, the accompanying documentation of every course was structured and reviewed in accordance with current requirements. Syllabuses, being the acquirer’s main source of information about the educational components, are adapted as much as possible to be understandable and accessible. All documents are posted in the public domain on the web pages of the departments. Considerable attention is paid to the formation of professional competences, which ensure the study results, outlined in the course curriculum. At the same time, personalization of education is implemented through the development of personal skills and interests of an acquirer at elective components of the educational program as well as during extracurricular scientific and civic activities.
- Open Access
- 29 October 2021
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 5(33),p. 57-63
Comparative analysis of the fatty acid composition of raw material of rye (Khamarka variety) and barley (Shedevr variety) of Ukrainian selection
Introduction. Sowing rye (Secale cereale L.) and common barley (Hordéum vulgáre L.) are annual herbaceous plants of the Poaceae family, they are widely cultivated in many countries around the world as cereals and fodder crops. Sufficient raw material base of sowing rye and barley makes them promising sources for new drugs. Materials and methods. The fatty acid composition in lipophilic fractions of seeds, stems and leaves of sowing (Khamarka variety) and common barley (Shedevr variety) was studied by gas chromatography. Results. As a result of the study, the quantitative content of 14 fatty acids in the stems and leaves of barley, 13 – in the leaves of rye and 12 – in the stems of rye and in both types of studied seeds was identified and established. In all types of the studied raw materials, unsaturated fatty acids were quantitatively predominant, the content of which prevailed in seeds of rye – 82.89 % and barley – 76.35 %. In stems of common barley their content was 64.04 %, leaves of common barley – 66.31 % of the amount. In stems and leaves of rye, the predominance of unsaturated fatty acids over saturated ones was insignificant: 49.00 % vs. 47.05 % and 53.70 % vs. 43.03 %, respectively. Among the unsaturated fatty acids, linoleic and linolenic acids dominated. Palmitic acid predominated among the saturated raw materials in all types of studied raw materials Conclusions. Quantitative content of fatty acids in seeds, stems and leaves of sowing rye (Khamarka variety) and common barley (Shedevr variety) was identified and established by gas chromatography. The results of the research indicate a rich fatty acid composition of the studied raw materials and can be used to create drugs based on them
- 29 October 2021
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 5(33),p. 57-63
Open AccessComparative analysis of the fatty acid composition of raw material of rye (Khamarka variety) and barley (Shedevr variety) of Ukrainian selection
Introduction. Sowing rye (Secale cereale L.) and common barley (Hordéum vulgáre L.) are annual herbaceous plants of the Poaceae family, they are widely cultivated in many countries around the world as cereals and fodder crops. Sufficient raw material base of sowing rye and barley makes them promising sources for new drugs. Materials and methods. The fatty acid composition in lipophilic fractions of seeds, stems and leaves of sowing (Khamarka variety) and common barley (Shedevr variety) was studied by gas chromatography. Results. As a result of the study, the quantitative content of 14 fatty acids in the stems and leaves of barley, 13 – in the leaves of rye and 12 – in the stems of rye and in both types of studied seeds was identified and established. In all types of the studied raw materials, unsaturated fatty acids were quantitatively predominant, the content of which prevailed in seeds of rye – 82.89 % and barley – 76.35 %. In stems of common barley their content was 64.04 %, leaves of common barley – 66.31 % of the amount. In stems and leaves of rye, the predominance of unsaturated fatty acids over saturated ones was insignificant: 49.00 % vs. 47.05 % and 53.70 % vs. 43.03 %, respectively. Among the unsaturated fatty acids, linoleic and linolenic acids dominated. Palmitic acid predominated among the saturated raw materials in all types of studied raw materials Conclusions. Quantitative content of fatty acids in seeds, stems and leaves of sowing rye (Khamarka variety) and common barley (Shedevr variety) was identified and established by gas chromatography. The results of the research indicate a rich fatty acid composition of the studied raw materials and can be used to create drugs based on them
- Open Access
- 1 June 2020
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 33 (2) , 57-60
Comparative characteristics of proton pump inhibitor effectiveness in the treatment of gastric ulcer and duodenal ulcer
Aim. The aim of this study is to evaluate the efficiency of proton pump inhibitors in the treatment of gastric and duodenal ulcers as based on literature. Materials and methods: The materials of this research are the results of 86 original studies on the effectiveness of proton pump inhibitors analysis. Methods. Descriptive, statistical, retrospective. Results and Conclusion. According to the clinical random researches, Omeprazole preparations are not included in the list due to proven better effectiveness of Esomeprazole drugs. Moreover, lansoprazole drugs are not included according to proven short-acid inhibitory effect. In addition, the brand of mentioned above preparation does not exist on the pharmaceutical market of Ukraine. Furthermore, rabeprazole preparations are presented in the research by Pariet (brand) and by the effective generic Barol, while pantoprazole preparations are represented in the research by Kontrolok (brand) and by the generic Pultset, as well as by Nolpaza. Herein, the Pantosan effect was not significantly different from the effect of Pultset and Nolpaza, but the preparation is much more expensive. In terms of efficiency (%), 4 week repair of mucosal defects was carried out by way of the following treatment regimens: Barol + Amoxicillin + Clarythromycin (90.9±6.2), Pariet + Amoxicillin + Clarythromycin (83±2.6), Kontrolok + Amoxicillin + Clarythromycin (100±1.3), Pultset + Amoxicillin + Clarythromycin (88±4.1), Nolpaza + Amoxicillin + Clarythromycin (72±4.1), Ezolonh + Amoxicillin + Clarythromycin (87.7±3.8), Neksium + Amoxicillin + Clarythromycin (96.1±3.1).
- 1 June 2020
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 33 (2) , 57-60
Open AccessComparative characteristics of proton pump inhibitor effectiveness in the treatment of gastric ulcer and duodenal ulcer
Aim. The aim of this study is to evaluate the efficiency of proton pump inhibitors in the treatment of gastric and duodenal ulcers as based on literature. Materials and methods: The materials of this research are the results of 86 original studies on the effectiveness of proton pump inhibitors analysis. Methods. Descriptive, statistical, retrospective. Results and Conclusion. According to the clinical random researches, Omeprazole preparations are not included in the list due to proven better effectiveness of Esomeprazole drugs. Moreover, lansoprazole drugs are not included according to proven short-acid inhibitory effect. In addition, the brand of mentioned above preparation does not exist on the pharmaceutical market of Ukraine. Furthermore, rabeprazole preparations are presented in the research by Pariet (brand) and by the effective generic Barol, while pantoprazole preparations are represented in the research by Kontrolok (brand) and by the generic Pultset, as well as by Nolpaza. Herein, the Pantosan effect was not significantly different from the effect of Pultset and Nolpaza, but the preparation is much more expensive. In terms of efficiency (%), 4 week repair of mucosal defects was carried out by way of the following treatment regimens: Barol + Amoxicillin + Clarythromycin (90.9±6.2), Pariet + Amoxicillin + Clarythromycin (83±2.6), Kontrolok + Amoxicillin + Clarythromycin (100±1.3), Pultset + Amoxicillin + Clarythromycin (88±4.1), Nolpaza + Amoxicillin + Clarythromycin (72±4.1), Ezolonh + Amoxicillin + Clarythromycin (87.7±3.8), Neksium + Amoxicillin + Clarythromycin (96.1±3.1).
- Open Access
- 1 September 2019
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 32 (3) , 168-172
Biochemical aspects of KB-28 compound on physically loaded study subjects
In previous studies of actoprotective activity of 5-R-thio-tetrazolo[1,5]quinazoline derivatives in normal and complicated experimental conditions, sodium 2-(tetrazolo [1,5-c]quinazoline-5-ylthio)acetate (KB-28) was found to be the leader of the experiment. The objective of the current study was to characterize the effects of KB-28 compounds on carbohydrate and lipid exchange indices under the conditions of physical load as a possible mechanism of actoprotective effect. In the course of the experiment, the indices of carbohydrate and lipid exchange in the muscle, blood and liver of animal models were determined following a 15-day physical load course. In doing so, glucose, glycogen and total lipid concentrations were assessed. The KB-28 compound was administered daily at levels determined during the course of regular physical load normalized metabolic processes in rats. The results were then compared to a control which received intraperitoneally the equivolume 0.9% sodium chloride solution. The phenomenon of actoprotection consisted in enhancing concentrations of glycogen in skeletal muscles and liver. Compared to the control figures, this increase was 28.8% and 25.0%, accordingly. Moreover, the course of KB-28 caused a statistically significant reduction (by 32.1%) of the total serum lipid concentration in the animals under physical load. The effect may be a sign of the ability of this substance to utilize active lipolysis for improvement of the skeletal muscle performance. Having analyzed the results obtained, we can draw a conclusion that influencing the biochemical processes in the study models is one of the mechanisms of the KB-28 actoprotective effect.
- 1 September 2019
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 32 (3) , 168-172
Open AccessBiochemical aspects of KB-28 compound on physically loaded study subjects
In previous studies of actoprotective activity of 5-R-thio-tetrazolo[1,5]quinazoline derivatives in normal and complicated experimental conditions, sodium 2-(tetrazolo [1,5-c]quinazoline-5-ylthio)acetate (KB-28) was found to be the leader of the experiment. The objective of the current study was to characterize the effects of KB-28 compounds on carbohydrate and lipid exchange indices under the conditions of physical load as a possible mechanism of actoprotective effect. In the course of the experiment, the indices of carbohydrate and lipid exchange in the muscle, blood and liver of animal models were determined following a 15-day physical load course. In doing so, glucose, glycogen and total lipid concentrations were assessed. The KB-28 compound was administered daily at levels determined during the course of regular physical load normalized metabolic processes in rats. The results were then compared to a control which received intraperitoneally the equivolume 0.9% sodium chloride solution. The phenomenon of actoprotection consisted in enhancing concentrations of glycogen in skeletal muscles and liver. Compared to the control figures, this increase was 28.8% and 25.0%, accordingly. Moreover, the course of KB-28 caused a statistically significant reduction (by 32.1%) of the total serum lipid concentration in the animals under physical load. The effect may be a sign of the ability of this substance to utilize active lipolysis for improvement of the skeletal muscle performance. Having analyzed the results obtained, we can draw a conclusion that influencing the biochemical processes in the study models is one of the mechanisms of the KB-28 actoprotective effect.
- 3 May 2018
- Published by Ternopil State Medical University in Medical and Clinical Chemistry
- No. 1
Дослідження стероїдних сполук у талабану польового екстракті густому (Thlaspiarvense L.)
Introduction. Environment, lowered physical activity and low standards of living lead to the increase of incidence of diseases in the population of Ukraine, in particular, pathologies of prostate in men. Creation of plant-derived medicines for the treatment of the abovementioned pathologies is of great interest nowadays. Phytomedicines possess low toxicity andare characterized by high safety level, absence of negative action towards sexual function, possibility of long-term usage in complex therapy. Phytoremedies with prostate protective activity usually include extracts of plants that show anti-inflammatory, immune stimulating, spasmolytic, diuretic, antioxidant, antitumor activity. Field pennycress belongs to the prospective sources of obtaining prostate protective remedies. Field pennycress (Thlaspiarvense L.) from cabbage family (Brassicaceae) shows the abovementioned types of activity, thus it is used for the prophylaxis and treatment of benign prostate hyperplasia. Among biologically active compounds of herbal medicines a certain role in reaching therapeutic effect play steroidal compounds, which show prostate protective, cytostatic activity. Thus, for a more detailed research on field pennycress herb its thick extract was obtained, in which the qualitative composition and quantitative content of steroidal compounds was studied.Research Methods. Gas chromatography was used for the phytosterols’ study in the thick extract of field pennycress herb.Results and Discussion. 3 compounds were identified using the gas chromatography method: stigmasterol, sitosterol and lanosta-9(11),24-diene-3-ol acetate and their quantitative content (0.12 mg/kg, 0.16 mg/kg, 0.29 mg/kgrespectively) was determined in the thick extract of field pennycress herb.Conclusions. The obtained results might be used at quality control methods development for the thick extract of field pennycress herb.
- 3 May 2018
- Published by Ternopil State Medical University in Medical and Clinical Chemistry
- No. 1
Дослідження стероїдних сполук у талабану польового екстракті густому (Thlaspiarvense L.)
Introduction. Environment, lowered physical activity and low standards of living lead to the increase of incidence of diseases in the population of Ukraine, in particular, pathologies of prostate in men. Creation of plant-derived medicines for the treatment of the abovementioned pathologies is of great interest nowadays. Phytomedicines possess low toxicity andare characterized by high safety level, absence of negative action towards sexual function, possibility of long-term usage in complex therapy. Phytoremedies with prostate protective activity usually include extracts of plants that show anti-inflammatory, immune stimulating, spasmolytic, diuretic, antioxidant, antitumor activity. Field pennycress belongs to the prospective sources of obtaining prostate protective remedies. Field pennycress (Thlaspiarvense L.) from cabbage family (Brassicaceae) shows the abovementioned types of activity, thus it is used for the prophylaxis and treatment of benign prostate hyperplasia. Among biologically active compounds of herbal medicines a certain role in reaching therapeutic effect play steroidal compounds, which show prostate protective, cytostatic activity. Thus, for a more detailed research on field pennycress herb its thick extract was obtained, in which the qualitative composition and quantitative content of steroidal compounds was studied.Research Methods. Gas chromatography was used for the phytosterols’ study in the thick extract of field pennycress herb.Results and Discussion. 3 compounds were identified using the gas chromatography method: stigmasterol, sitosterol and lanosta-9(11),24-diene-3-ol acetate and their quantitative content (0.12 mg/kg, 0.16 mg/kg, 0.29 mg/kgrespectively) was determined in the thick extract of field pennycress herb.Conclusions. The obtained results might be used at quality control methods development for the thick extract of field pennycress herb.